J.P. Morgan Healthcare Conference
|
|
- Kenneth Parrish
- 5 years ago
- Views:
Transcription
1 J.P. Morgan Healthcare Conference January 15, 2014 Greg Wasson President and CEO 2 1
2 Safe Harbor and Non-GAAP Certain statements and projections of future results made in these presentations constitute forward-looking statements that are based on current market, competitive and regulatory expectations that involve risk and uncertainty. Except to the extent required by the law, we undertake no obligation to update publicly any forward-looking statement after these presentations, whether as a result of new information, future events, changes in assumptions or otherwise. Please see our latest Form 10-K &10-Q filings for a discussion of risk factors as they relate to forward-looking statements. Today s presentation includes certain non-gaap financial measures, and we refer you to the Appendix to the presentation materials available on our investor relations website for reconciliations to the most directly comparable GAAP financial measures and related information. 3 A Walgreens Welcome to San Francisco 135 Powell St. San Francisco (Corner of Powell and O Farrell) 4 2
3 Our Journey Over the Past 5 Years Slowed store openings to focus on core Strategic acquisitions brought leading-edge concepts Launched Balance Rewards loyalty program Alliance Boots partnership and longterm strategic relationship with AmerisourceBergen 5 Our Purpose and Vision Our Purpose... To help people get, stay and live well Our Vision... To be the first choice in healthy and daily living for everyone in America and beyond 6 3
4 Our Strategic Growth Drivers Creating a Well Experience Advancing Community Pharmacy Establishing an Efficient Global Platform 7 Creating Value for our Shareholders Our Progress over the Past 5 Years GAAP Net Earnings: ~$11B Adjusted Net Earnings: ~$13B* Operating Cash Flow: ~$20B Total Shareholder Return: 145% * Non-GAAP Financial Measures see Appendix. 8 4
5 Today s Agenda Industry Trends Strategic Growth Drivers Value Creation 9 Dynamic Industry - Healthcare Healthcare spend is 17% of GDP, growing to 20% by ,000 Americans turning 65 daily -- spending twice as much on healthcare Healthcare reform adding 30 million insured Americans 10 5
6 Dynamic Industry - Healthcare 70% of Americans who visit the ER don t have or don t utilize a primary care physician Emerging healthcare delivery models Shifting from fee-for-service to payfor-performance RPh w/ patient 11 Dynamic Industry - Retail Consumers looking for value Blurring of retail channels Growing digital commerce 12 6
7 How Walgreens is Best Positioned 8,200 health and daily living destinations 70,000 of the most trusted professionals in healthcare 400 healthcare clinics 370 worksite clinics 200 health system pharmacies 75 infusion pharmacies 2 central fill mail facilities 2 central specialty care centers How Walgreens is Best Positioned Over 11,000 stores and 370 distribution centers operating in 25 countries* *Including associates and joint ventures of Alliance Boots 14 7
8 Our Strategic Growth Drivers Creating a Well Experience Advancing Community Pharmacy Establishing an Efficient Global Platform 15 Creating a Well Experience Opened or converted more than 600 Well Experience locations to date Extraordinary customer care Right products and solutions Every community in America 16 8
9 Stepping Out to Create Something New & Unique... Manhattan Beach, CA Flagship, Chicago Johns Hopkins Medical Net Zero, Evanston, IL 17 Accelerated Daily Living Trends 3% Front End Comp Store Sales % Change 2% YOY % Change 1% 0% -1% -2% -3% Dec Jan Feb Mar/Apr May June July One - Year % Change Two - Year Stack Aug Sep Oct Nov Dec One-Year -2.3% -0.4% -1.4% -0.2% 1.2% 0.8% 2.3% 2.2% 2.9% 2.3% 1.9% 2.5% Two-Year -1.7% 1.2% 0.6% -0.7% 0.2% -0.2% -0.1% 1.6% 1.4% -0.6% 0.2% 0.2% *February FE Comp excludes the benefit of Leap Day FY 2013 FY
10 Our Strategic Growth Drivers Creating a Well Experience Advancing Community Pharmacy Establishing an Efficient Global Platform 19 Advancing Community Pharmacy Patient Adherence Improves Outcomes Increased pharmacist time with patient Non-adherence costs U.S. healthcare system $300B/year Studies find improved adherence after one on one consultation with pharmacist 1. Outcomes Pharmaceutical Health Care, Accessed April 24, Isetts BJ et al. Am J Pharm Assoc. 2008;48:
11 Advancing Community Pharmacy Growing Immunizations Estimated Size of US Immunization Market* Hep A/ Hep B Meningitis Pneumococcal/ Zoster/ Varicella $1.5B $0.9B $1.2B TetDipPertussis/Td $1.2B $10.3B $2.0B Seasonal Influenza $3.5B HPV Walgreens Immunizations Administered 10 Millions FY09 FY10 FY11 FY12 FY13 *Walgreen Co. Estimates 21 Advancing Community Pharmacy Centers of Excellence (COE) COE staffed by specially trained pharmacists 89% of the US HIV population has access to one of our 750 HIV Centers of Excellence Expanding centers for other complex diseases like multiple sclerosis and cystic fibrosis 22 11
12 Advancing Community Pharmacy Expanding the Offering at Healthcare Clinics 23 Advancing Community Pharmacy Innovative Offerings: Diagnostics Lab tests on samples as small as 1/1,000 the size of a typical blood draw Results to you and your doctor in less than four hours, on average Pricing dramatically low rates and accepting major insurance carriers as well as Medicare and Medicaid
13 Advancing Community Pharmacy Specialty and Infusion Specialty is the fastest growing pharmacy segment -- with 3% of the population projected to drive 50% of total drug spend by 2017 Walgreens is well positioned with the integrated multi-channel assets in place Offering the largest home infusion network in the nation 25 Advancing Community Pharmacy Differentiated Experience Accessible pharmacist Mobile/online Privacy for health tests Integrated healthcare Convenient prescription pick-up 26 13
14 Advancing Community Pharmacy Focusing on Patient Care through Strategic Partnerships Johns Hopkins Medicine Stanford University Cancer Research Center 27 Advancing Community Pharmacy Walgreens Well Transitions Program Overall Unplanned Admissions Hospitals <30 Days by TIme Well Transitions Procedure: -Bedside delivery of discharge medications -Medication reconciliation -Two follow-up phone calls to reinforce adherence -Continuity with Walgreens community pharmacists Readmissions % 25% 20% 15% 10% 5% Patients eligible but not enrolled Patients enrolled in program 20.0% 18.4% 13.1% 12.8% 21.3% 10.0% 0% CY13 Q1 CY13 Q2 CY13 Q
15 Advancing Community Pharmacy Building Physician Partnerships 29 Advancing Community Pharmacy Winning Medicare Part D Preferred Plans Med D Volume Growth 52wks through Nov 2013 vs LY. 30-day equivalent prescriptions Market 14.1% Walgreens 21.2% Other Chain Drug 14.0% Independents 8.0% Food 17.3% Mass 13.4% 30 15
16 Advancing Community Pharmacy 90-Day at Retail Walgreens 90-Day at Retail Prescriptions (30-Day Equivalents) Millions +22.2% CAGR Growth in Industry Mail Prescriptions* 2% 1.1% 0.0% 0.3% 0% -2% -4% -6% -5.8% -8% -7.6% 0 FY09 FY10 FY11 FY12 FY13-10% FY09 FY10 FY11 FY12 FY13 *IMS Data 31 Solid Script Momentum 8% Script Comp Store % Change 6% YOY % Change 4% 2% 0% -2% -4% Dec Jan Feb Mar Apr May June One - Year % Change Two - Year Stack July Aug Sep Oct Nov Dec One-Year -2.2% 7.2% 6.4% 7.4% 6.0% 7.3% 7.2% 7.1% 7.7% 6.1% 6.1% 4.0% 3.6% Two-Year 0.6% -1.1% -1.9% -1.2% -2.1% -1.7% -2.1% -0.6% 0.7% -0.4% 0.5% 1.1% 1.4% Comp Data Adjustments: Day Fall, 90 Day, Flu Shot, and Flu Script FY 2013 FY
17 Our Strategic Growth Drivers... Creating a Well Experience Advancing Community Pharmacy Establishing an Efficient Global Platform 33 Establishing an Efficient Global Platform Greater Scale and Global Reach Streamline global pharmaceutical supply chain Increase patient access to pharmaceuticals Easier for Pharma to bring new products and solutions to market Global sourcing benefits 34 17
18 Establishing an Efficient Global Platform Synergy Work Streams Six Synergy Work Streams Generics Branded Products (Pharma) Combined Synergies with Alliance Boots $1B $1,000 $800 Branded Products (Non-Pharma) Own Brands and General Merch. $600 $400 $350M- $400M Goods not for Resale Front of Store Growth $200 $154M $0 FY13 FY14E FY16 Goal Forward-Looking Statements See cautionary note in attached Appendix. 35 Establishing an Efficient Global Platform AmerisourceBergen Distribution Agreement Strategic Collaboration Equity Alignment 36 18
19 Progress on Long-Term Goals... FY 2016 Goals + Revenue Operating Income (GAAP) Adjusted Operating Income* Synergies Operating Cash Flow >$130 Billion $8.5 - $9.0 Billion $9.0 - $9.5 Billion $1 Billion ~$8 Billion Net Debt** ~$11 Billion Forward-Looking Statements See cautionary note in attached Appendix. All figures assume constant currency and exercise of option to acquire remaining 55% interest. All financial goals assume no major mergers and acquisitions or strategic transactions. * Non-GAAP Financial Measures see Appendix. ** Net debt defined as balance sheet debt less cash and cash equivalents. Net debt excludes lease obligations. ~ 1.1B shares projected to be outstanding in FY Projected shares outstanding assumes no share repurchases. 37 Capital Allocation for Future Value Creation Maintain Strong Balance Sheet and Financial Flexibility Reinvest in Core Strategies Return Cash to Shareholders Invest in Strategic Opportunities 38 19
20 Reinvesting in Core Strategies Over Past 5 Years Cumulative Cap Ex: ~$7B New Locations: 1,648 Well Experience Stores: Investing in Strategic Opportunities Over Past 5 Years, Cumulative M&A & Strategic Investments: ~$10B* Retail Consolidation Omni-Channel Access Snyder s Strategic Partnerships Healthcare Expansion *Includes cash and equity investments Crescent Healthcare Omnicare Infusion Cardinal Specialty Rx Solutions McKesson Specialty BioScrip Specialty 40 20
21 Dividend and Total Shareholder Return $ 1.40 Dividends Paid per Fiscal Year in Dollars $ Year Total Shareholder Return CAGR % Year Total Shareholder Return CAGR % Year Total Shareholder Return CAGR % E At the Corner of Happy and Healthy 42 21
22 Appendix The following information provides reconciliations of the supplemental non-gaap financial measures, as defined under SEC rules, presented in this presentation to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles in the United States (GAAP). The company has provided these non-gaap financial measures in the presentation, which are not calculated or presented in accordance with GAAP, as supplemental information in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-gaap financial measures are presented because management has evaluated the company s financial results both including and excluding the adjusted items and believes that the non-gaap financial measures presented provide additional perspective and insights when analyzing the core operating performance of the Company s business from period to period and trends in the company s historical operating results. These supplemental non-gaap financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented in the presentation. The company does not provide a non-gaap reconciliation for non-gaap estimates on a forward-looking basis where it is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. 43 Reconciliation of Adjusted Net Earnings Net Earnings (GAAP) Acquisition Related Costs Hurricane Sandy Acquisition Related Amortization LIFO Provision $ in Millions Gain on WHI Sale Fair Market Value of warrants Adjustment DEA Settlement Costs Medicare Part D Organizational Efficiency Costs Alliance Boots Related Tax Adjusted Net Earnings (Non-GAAP) Fiscal 2009 Q Q Q Q Full Year 2, ,209 Fiscal 2010 Q Q Q Q Full Year 2, ,337 Fiscal 2011 Q Q Q Q (273) Full Year 2, (273) ,710 Fiscal 2012 Q Q Q Q Full Year 2, ,565 Fiscal 2013 Q Q (13) Q (48) Q (5) - (62) Full Year 2, (13) (110) ,
23 Fiscal 2014 Reconciliation of Adjusted Net Earnings Net Earnings (GAAP) Acquisition Related Costs Hurricane Sandy Acquisition Related Amortization LIFO Provision $ in Millions Gain on WHI Sale Fair Market Value of warrants Adjustment DEA Settlement Costs Medicare Part D Organizational Efficiency Costs Alliance Boots Related Tax Adjusted Net Earnings (Non-GAAP) Q (161) Reconciliation of Free Cash Flow $ in Millions 1Q08 2Q08 3Q08 4Q08 1Q09 2Q09 3Q09 4Q09 Cash Flow from Operations (GAAP) $390 $1,116 $985 $548 $312 $1,428 $1,519 $852 Capital Expenditures (GAAP) (490) (553) (610) (572) (638) (454) (442) (393) Free Cash Flow (Non- GAAP)* ($100) $563 $375 ($24) ($326) $974 $1,077 $459 *Free cash flow is defined as net cash provided by operating activities in a period minus additions to property and equipment (capital expenditures) made in that period. This measure does not represent residual cash flows available for discretionary expenditures as the measure does not deduct the payments required for debt service and other contractual obligations or payments for future business acquisitions. Therefore, we believe it is important to view free cash flow as a measure that provides supplemental information to our entire statements of cash flows
24 Reconciliation of Free Cash Flow $ in Millions 1Q10 2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 Cash Flow from Operations (GAAP) $1,168 $595 $1,056 $925 $1,165 $886 $1,230 $362 Capital Expenditures (GAAP) (304) (220) (262) (228) (273) (196) (230) (514) Free Cash Flow (Non- GAAP)* $864 $375 $794 $697 $892 $690 $1,000 ($152) *Free cash flow is defined as net cash provided by operating activities in a period minus additions to property and equipment (capital expenditures) made in that period. This measure does not represent residual cash flows available for discretionary expenditures as the measure does not deduct the payments required for debt service and other contractual obligations or payments for future business acquisitions. Therefore, we believe it is important to view free cash flow as a measure that provides supplemental information to our entire statements of cash flows. 47 Reconciliation of Free Cash Flow $ in Millions 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 Cash Flow from Operations (GAAP) $809 $1,007 $1,847 $768 $601 $1,198 $1,379 $1,123 Capital Expenditures (GAAP) (419) (304) (379) (448) (336) (245) (293) (338) Free Cash Flow (Non- GAAP)* $390 $703 $1,468 $320 $265 $953 $1,086 $785 *Free cash flow is defined as net cash provided by operating activities in a period minus additions to property and equipment (capital expenditures) made in that period. This measure does not represent residual cash flows available for discretionary expenditures as the measure does not deduct the payments required for debt service and other contractual obligations or payments for future business acquisitions. Therefore, we believe it is important to view free cash flow as a measure that provides supplemental information to our entire statements of cash flows
25 Reconciliation of Free Cash Flow $ in Millions 1Q14 Cash Flow from Operations (GAAP) $133 Capital Expenditures (GAAP) (364) Free Cash Flow (Non-GAAP)* (231) *Free cash flow is defined as net cash provided by operating activities in a period minus additions to property and equipment (capital expenditures) made in that period. This measure does not represent residual cash flows available for discretionary expenditures as the measure does not deduct the payments required for debt service and other contractual obligations or payments for future business acquisitions. Therefore, we believe it is important to view free cash flow as a measure that provides supplemental information to our entire statements of cash flows. 49 Certain Definitions & Assumptions CERTAIN ASSUMPTIONS: Unless the context otherwise indicates or requires: This presentation assumes constant currency exchange rates after the date hereof based on current rates; References to the combined company and pro forma combined financial and other information assume that Walgreens has elected to exercise its option in Step 2 during the period in 2015 when it has the right to do so; Walgreens transaction with Alliance Boots does not include the benefit of Alliance Boots minority interest in Galenica Ltd., a Swiss healthcare group, so Walgreens shareholders will not benefit from the financial performance of Galenica Ltd. even though Alliance Boots proportionate interest in their profits is reflected in Alliance Boots financial statements for periods prior to May 10, 2013; and All financial goals assume no major mergers and acquisitions or other strategic transactions. Trading Profit - Profit from operations before amortization of customer relationships and brands, exceptional items and share of post-tax earnings of associates and joint ventures Historical Alliance Boots Financial Information Alliance Boots audited consolidated financial statements for the years ended March 31, 2013 and 2012 were filed as Exhibit 99.1 to the Walgreen Co. Form 8-K filed on May 15, Such financial statements of Alliance Boots were prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (IFRS) and audited in accordance with auditing standards generally accepted in the United States. All descriptions of the company s agreements relating to Alliance Boots and the arrangements and transactions contemplated thereby in this presentation are qualified in their entirety by reference to the full text of the agreements, copies of which have been filed with the SEC. See the Company s Form 8-K filings on June 19, 2012, August 6, 2012, September 10, 2012 and September 13, All descriptions in this presentation of the agreements relating to the strategic long-term relationship with AmerisourceBergen announced by the Company and Alliance Boots on March 18, 2013 and the arrangements and transactions contemplated thereby are qualified in their entirety by reference to the description and the full text of the agreements in the Company s Form 8-K filing on March 20,
26 Cautionary Note Regarding Forward-Looking Statements Cautionary Note Regarding Forward-Looking Statements. Statements in these materials and the accompanying presentation that are not historical, including, without limitation, estimates of future financial and operating performance, including the amounts and timing of future accretion and synergies, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of Words such as "expect," "likely," "outlook," "forecast, "would," "could," "should," "can," "will," "project," "intend," "plan," "goal," target, "continue," "sustain," "synergy," "on track," "believe," "seek," "estimate," "anticipate," "may," "possible," "assume," variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, those relating to our commercial agreement with AmerisourceBergen, the arrangements and transactions contemplated by our Framework Agreement with AmerisourceBergen and Alliance Boots and their possible effects, the Purchase and Option Agreement and other agreements relating to our strategic partnership with Alliance Boots, the arrangements and transactions contemplated thereby and their possible effects, the parties' ability to realize anticipated synergies and achieve anticipated financial results, the risks associated with transitions in supply arrangements, the risks associated with international business operations, the risks associated with governance and control matters in minority investments, whether the option to acquire the remainder of the Alliance Boots equity interest will be exercised and the financial ramifications thereof, the risks associated with equity investments in AmerisourceBergen including whether the warrants to invest in AmerisourceBergen will be exercised and the financial ramifications thereof, changes in vendor, payer and customer relationships and terms, changes in network participation, the implementation, operation and growth of our customer loyalty program, changes in economic and market conditions, competition, risks associated with new business areas and activities, risks associated with acquisitions, joint ventures and strategic investments, the ability to realize anticipated results from capital expenditures and cost reduction initiatives, outcomes of legal and regulatory matters, and changes in legislation or regulations. These and other risks, assumptions and uncertainties are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K, which is incorporated herein by reference, and in other documents that we file or furnish with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Except to the extent required by law, Walgreens does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the initial distribution of this presentation, whether as a result of new information, future events, changes in assumptions or otherwise
Walgreens-Alliance Boots Investor Call
Walgreens-Alliance Boots Investor Call August 6, 2014 Investor Call Agenda Introduction & Safe Harbor Alliance Boots Step 2 Update Global Management Structure Corporate Structure Rick Hans, CFA Divisional
More informationWalgreen Co. Reports Fiscal 2013 First Quarter Results
December 21, 2012 Walgreen Co. Reports Fiscal 2013 First Quarter Results Company reports adjusted first quarter earnings per diluted share of 58 cents, compared with adjusted earnings per diluted share
More informationWalgreens Boots Alliance 2015 analyst meeting financial session. Safe Harbor and Non-GAAP
Walgreens Boots Alliance 2015 analyst meeting financial session 16 April 2015 Safe Harbor and Non-GAAP Certain statements and projections of future results made in this presentation constitute forward-looking
More informationWalgreens Boots Alliance Fiscal year end 2015 and 4Q earnings conference call. 28 October 2015
Walgreens Boots Alliance Fiscal year end 2015 and 4Q earnings conference call 28 October 2015 Fiscal year end 2015 and 4Q earnings call agenda Topic Introduction & Safe Harbor Business Overview Financial
More informationFourth Quarter and Fiscal 2016 Results. 20 October 2016
Fourth Quarter and Fiscal 2016 Results 20 October 2016 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that
More informationWalgreen Co. Reports Fiscal 2014 Second Quarter Results
March 25, 2014 Walgreen Co. Reports Fiscal 2014 Second Quarter Results Company reports adjusted second quarter earnings per diluted share of 91 cents, compared with adjusted earnings per diluted share
More informationFiscal 2017 First Quarter Results. 5 January 2017
Fiscal 2017 First Quarter Results 5 January 2017 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not
More informationFiscal 2018 Third Quarter Results. 28 June 2018
Fiscal 2018 Third Quarter Results 28 June 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not
More informationSafe harbor and non-gaap
Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not historical including, without limitation, estimates
More informationFiscal 2019 First Quarter Results. December 20, 2018
Fiscal 2019 First Quarter Results December 20, 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are
More informationWalgreens Boots Alliance 3Q16 Consolidated Financial Results Earnings conference call. 6 July 2016
Walgreens Boots Alliance 3Q16 Consolidated Financial Results Earnings conference call 6 July 2016 Agenda Topic Introduction & safe harbor Opening remarks Financial review Questions & answers Speaker Gerald
More informationFourth Quarter and Fiscal 2018 Results. October 11, 2018
Fourth Quarter and Fiscal 2018 Results October 11, 2018 Safe harbor and non-gaap Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that
More informationWalgreens Boots Alliance Reports Fourth Quarter and Fiscal 2017 Results
October 25, 2017 Boots Alliance Reports Fourth Quarter and Fiscal 2017 Results Fourth quarter highlights GAAP diluted net earnings per share were $0.76, down 20.0 percent from the year-ago quarter due
More informationWalgreens Boots Alliance Reports Fiscal 2018 Second Quarter Results
March 28, 2018 Alliance Reports Fiscal 2018 Second Quarter Results Second quarter highlights GAAP diluted net earnings per share were $1.36, up 38.8 percent from the year-ago quarter; Adjusted diluted
More informationWalgreens Boots Alliance Reports Fiscal 2018 Third Quarter Results
Alliance Reports Fiscal 2018 Third Quarter Results June 28, 2018 Third quarter highlights GAAP diluted net earnings per share increased 26.2 percent from the year-ago quarter, to $1.35; Adjusted diluted
More informationWalgreens Boots Alliance Reports Fiscal 2019 First Quarter Results Delivers Double Digit Percentage Growth in Earnings Per Share (EPS)
Walgreens Boots Alliance Reports Fiscal 2019 First Quarter Results Delivers Double Digit Percentage Growth in Earnings Per Share (EPS) First quarter highlights, year-over-year Sales increased 9.9 percent
More informationWalgreens Boots Alliance Reports Fiscal 2017 First Quarter Results
Walgreens Boots Alliance Reports Fiscal 2017 First Quarter Results First quarter highlights GAAP diluted net earnings per share decrease 4.0 percent from the year-ago quarter, to $0.97; Adjusted diluted
More informationWalgreens Boots Alliance Reports Fiscal 2018 First Quarter Results
January 4, 2018 Walgreens Boots Alliance Reports Fiscal 2018 First Quarter Results First quarter highlights GAAP diluted net earnings per share were $0.81, down 16.5 percent from the year-ago quarter mainly
More informationWalgreens Boots Alliance Reports Fourth Quarter and Fiscal 2016 Results
20 October 2016 Boots Alliance Reports Fourth Quarter and Fiscal 2016 Results Fourth quarter highlights GAAP diluted net earnings per share increase to $0.95 from $0.02 in the year-ago quarter; Adjusted
More informationFiscal Year 2011 Core Strategies and Milestones Express Scripts Update
Walgreen Co. Reports 6.5 Percent Increase in Fourth Quarter Sales; Adjusted Earnings Per Diluted Share Increase to 57 Cents in Quarter, Excluding Gain from Sale of Walgreens Health Initiatives; and GAAP
More informationWalgreens Boots Alliance Reports Fiscal 2016 Third Quarter Results
Alliance Reports Fiscal 2016 Third Quarter Results GAAP third quarter net earnings attributable to Alliance per diluted share decrease 14.4 percent to $1.01 compared with the year-ago period; Adjusted
More informationWalgreens Boots Alliance Reports Fiscal 2016 Second Quarter Results
Alliance Reports Fiscal 2016 Second Quarter Results Adjusted second quarter net earnings attributable to Alliance per diluted share increase 11.0 percent to $1.31 compared with the year-ago period; GAAP
More informationWalgreens Boots Alliance Reports Fiscal 2015 Year-End and Fourth Quarter Results
October 28, 2015 Walgreens Boots Alliance Reports Fiscal 2015 Year-End and Fourth Quarter Results Adjusted fiscal year 2015 net earnings attributable to Walgreens Boots Alliance per diluted share increase
More informationWalgreen Co. Reports Fiscal 2012 Third Quarter Earnings of $537 Million, or 62 Cents per Diluted Share
June 19, 2012 Walgreen Co. Reports Fiscal 2012 Third Quarter Earnings of $537 Million, or 62 Cents per Diluted Share Results include 1 cent per diluted share due to costs related to strategic transaction
More informationJUNE 19, Creating The First Global Pharmacy-Led Health & Wellbeing Enterprise
JUNE 19, 2012 Creating The First Global Pharmacy-Led Health & Wellbeing Enterprise JUNE 19, 2012 Creating The First Global Pharmacy-Led Health & Wellbeing Enterprise FORWARD-LOOKING STATEMENT SAFE HARBOR
More information3 rd Quarter Fiscal 2019
3 rd Quarter Fiscal 2019 SUPPLEMENTAL INFORMATION December 19, 2018 SAFE HARBOR STATEMENT Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical,
More information34 th Annual J.P. Morgan Healthcare Conference. Steve Collis, President & CEO Tim Guttman, EVP & CFO
34 th Annual J.P. Morgan Healthcare Conference Steve Collis, President & CEO Tim Guttman, EVP & CFO January 12, 2016 Steve Collis President & CEO Cautionary Note Regarding Forward-Looking Statements Certain
More informationMcKesson Corporation J.P. Morgan Healthcare Conference
McKesson Corporation J.P. Morgan Healthcare Conference John Hammergren Chairman and Chief Executive Officer Forward-Looking Statements Some of the information in this presentation is not historical in
More informationFINANCIAL HIGHLIGHTS. Sales
Walgreen Co. Reports 11.4 Percent Increase in Diluted Earnings Per Share to 49 Cents for the Fourth Quarter 2010; Results Include 5 Cents Per Diluted Share of Acquisition and Restructuring Related Costs
More informationFourth Quarter 2017 Earnings Conference Call
Fourth Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 8, 2018 Important Information No Offer
More informationSafe Harbor Statement
June 27, 2018 Safe Harbor Statement Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical, are forward-looking statements made pursuant to the
More informationMcKesson Corporation J.P. Morgan Healthcare Conference
McKesson Corporation J.P. Morgan Healthcare Conference John Hammergren Chairman and Chief Executive Officer Forward-Looking Statements Some of the information in this presentation is not historical in
More informationMcKesson Corporation Fiscal 2018 Financial Performance Fiscal 2019 Annual Outlook. Financial Results and Company Highlights May 24, 2018
McKesson Corporation Fiscal 2018 Financial Performance Fiscal 2019 Annual Outlook Financial Results and Company Highlights Forward-Looking Statements Some of the information in this presentation is not
More informationFourth Quarter 2016 Earnings Conference Call
Fourth Quarter 2016 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer February 9, 2017 Revised 2/9 Forward-looking
More informationDelivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer
Delivering Value for All Health Care Stakeholders Larry Merlo President & Chief Executive Officer Agenda Our Value Proposition Has Never Been Stronger We See Compelling Opportunities in a Robust Health
More informationStanding strong for payers and patients
Standing strong for payers and patients Eric Slusser, EVP, Chief Financial Officer Everett Neville, SVP Supply Chain and Specialty B A N K O F A M E R I C A M E R R I L L L Y N C H H E A LTH C A RE CONFERENCE
More informationRaymond James 37 th Annual Institutional Investors Conference. March 8, 2016
Raymond James 37 th Annual Institutional Investors Conference March 8, 2016 Forward-looking statements and Non-GAAP financial measures Forward-looking statements Certain statements included in this presentation,
More informationSafe Harbor Statement
January 3, 2018 Safe Harbor Statement Statements in this presentation that are not historical, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation
More informationJune Investor Presentation
June 2014 Investor Presentation Safe Harbor Certain statements included herein, including guidance and those that express management's objectives and the strategies to achieve those objectives, as well
More informationRITE AID REPORTS NET INCOME AND RECORD ADJUSTED EBITDA FOR FOURTH QUARTER AND FULL 2014 FISCAL YEAR
Press Release For Further Information Contact: INVESTORS: MEDIA: Matt Schroeder Susan Henderson (717) 214-8867 (717) 730-7766 or investor@riteaid.com FOR IMMEDIATE RELEASE RITE AID REPORTS NET INCOME AND
More information35th Annual J.P. Morgan Healthcare Conference. January 12, 2017
35th Annual J.P. Morgan Healthcare Conference January 12, 2017 Safe Harbor Statement and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements regarding
More informationDiplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017
Diplomat s Acquisition of LDI Integrated Pharmacy Services Nov. 15, 2017 1 DISCLAIMERS NON-GAAP INFORMATION We define Adjusted EBITDA as net income (loss) before interest expense, income taxes, depreciation
More informationSafe Harbor Statement
January 10, 2018 2 Safe Harbor Statement Statements in this presentation that are not historical, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation
More informationSafe Harbor Statement
April 12, 2018 Safe Harbor Statement Cautionary Statement Regarding Forward Looking Statements Statements in this presentation that are not historical, are forward-looking statements made pursuant to the
More information36 th Annual J.P. Morgan Healthcare Conference. January 10, 2018
36 th Annual J.P. Morgan Healthcare Conference January 10, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationFourth Quarter 2018 Earnings Conference Call
Fourth Quarter 2018 Earnings Conference Call Larry Merlo President & Chief Executive Officer Eva Boratto Executive Vice President & Chief Financial Officer February 20, 2019 Cautionary Statement Regarding
More informationCIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE
CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE March 2018 Important Information for Investors and Shareholders FORWARD LOOKING STATEMENTS
More informationRITE AID REPORTS NET INCOME OF $127.8 MILLION AND ADJUSTED EBITDA OF $364.2 MILLION FOR SECOND QUARTER FISCAL 2015
Press Release For Further Information Contact: INVESTORS: MEDIA: Matt Schroeder Susan Henderson (717) 214-8867 (717) 730-7766 or investor@riteaid.com FOR IMMEDIATE RELEASE RITE AID REPORTS NET INCOME OF
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationEarnings. Larry Merlo. President & Chief Executive Officer. Executive Vice President & Chief Financial Officer. November 4, 2014
Third dquate Quarter Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 4, 2014 Forward-looking Statements
More informationEarnings Conference Call
First Quarter 2015 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer May 1, 2015 Forward-looking Statements During
More information2009 UBS Healthcare Services Conference
2009 UBS Healthcare Services Conference February 10, 2009 John H. Hammergren Chairman and Chief Executive Officer Safe Harbor Clause Some of the information in this presentation may constitute forwardlooking
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationPowering healthcare provider success
Powering healthcare provider success Now and in the future Investor Information September 2018 TRANSFORMING HEALTHCARE TOGETHER Premier Inc. 2018 1 Forward-looking statements and non-gaap financial measures
More informationMcKesson Corporation Q2 Fiscal 2019 Financial Performance. Financial Results and Company Highlights October 25, 2018
McKesson Corporation Q2 Fiscal 2019 Financial Performance Financial Results and Company Highlights October 25, 2018 Forward-Looking Statements Some of the information in this presentation is not historical
More informationPuma Biotechnology Earnings Call Commercial Update
Puma Biotechnology Earnings Call Commercial Update May 9, 2018 Forward-Looking Safe Harbor Statement This presentation contains forward-looking statements, including statements regarding the benefits of
More informationCIGNA CORPORATION. 37 th Annual J.P. Morgan Healthcare Conference January 7, David Cordani President and Chief Executive Officer
CIGNA CORPORATION 37 th Annual J.P. Morgan Healthcare Conference January 7, 2019 David Cordani President and Chief Executive Officer 2 Forward-looking statements and Non-GAAP measures CAUTIONARY STATEMENT
More informationQ4 AND FULL YEAR 2017 UPDATE. March 1, 2018
Q4 AND FULL YEAR 2017 UPDATE March 1, 2018 SAFE HARBOR STATEMENT This presentation and any statements made for and during any presentation or meeting contain forward-looking statements related to Synergy
More informationThird Quarter 2017 Earnings Conference Call
Third Quarter 2017 Earnings Conference Call Larry Merlo President & Chief Executive Officer Dave Denton Executive Vice President & Chief Financial Officer November 6, 2017 Forward-looking Statements This
More informationDaseke, Inc. Consolidating North America s Flatbed & Specialized Logistics Market
Daseke, Inc. Consolidating North America s Flatbed & Specialized Logistics Market Investor Presentation September 2017 Important Disclaimers Non-GAAP Financial Measures This presentation includes non-gaap
More informationCowen and Company 37 th Annual Health Care Conference. March 6, 2017
Cowen and Company 37 th Annual Health Care Conference March 6, 2017 Safe Harbor Statement and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements regarding
More informationStanding strong for payers and patients
Standing strong for payers and patients Dr. Steve Miller, SVP, Chief Medical Officer Ben Bier, VP Investor Relations W I L L I A M B L A I R 3 7 TH ANNUAL G ROWTH STOCK C ONFERENCE 6.14.17 1 Safe harbor
More information37 th Annual J.P. Morgan Healthcare Conference January 9, 2019
37 th Annual J.P. Morgan Healthcare Conference January 9, 2019 1 Disclaimer Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
More informationGenesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015
Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare
More informationFourth Quarter Earnings Presentation. March 29, 2016
Fourth Quarter Earnings Presentation March 29, 2016 Safe Harbor Agreement This presentation contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationCIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG 2015 RESULTS, EXPECTS REVENUE AND EARNINGS GROWTH IN 2016 o o o
More informationZebra Technologies Third-Quarter 2018 Results. November 6, 2018
Zebra Technologies Third-Quarter 2018 Results November 6, 2018 1 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements and
More informationMagellan Health. Cantor Fitzgerald Healthcare Conference September 26, 2017
Magellan Health Cantor Fitzgerald Healthcare Conference September 26, 2017 Cautionary Statement and Non-GAAP measures 2 This slide presentation and our accompanying oral comments include forward-looking
More informationQ4 & Full Year FY2018 Financial Results. November 6, 2018
Q4 & Full Year FY2018 Financial Results November 6, 2018 Cautionary Note Regarding Forward-Looking Statements Certain of the statements contained in this presentation are forward-looking statements within
More information36 th Annual J.P. Morgan Healthcare Conference January 9, Bruce D. Broussard President & CEO
36 th Annual J.P. Morgan Healthcare Conference January 9, 2018 Bruce D. Broussard President & CEO 0 Cautionary statement This presentation includes forward-looking statements within the meaning of the
More informationA Leading National Provider of Post-Acute Services
A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future
More informationA Leading National Provider of Post-Acute Services
A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future
More informationInvestor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE
Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President Investor Relations Corporate Communications (401) 770-4050 (401) 770-5717 FOR IMMEDIATE RELEASE CVS HEALTH
More informationAmerisourceBergen. CECP CEO Investor Forum Steve Collis, Chairman, President & CEO. February 25, 2019
AmerisourceBergen CECP CEO Investor Forum Steve Collis, Chairman, President & CEO February 25, 2019 Cautionary note regarding forward-looking statements Certain of the statements contained in this presentation
More informationCIGNA CORPORATION INVESTOR PRESENTATION. May 5, Cigna
CIGNA CORPORATION INVESTOR PRESENTATION May 5, 2017 1 Forward looking statements CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
More informationZebra Technologies Second-Quarter 2018 Results. August 7, 2018
Zebra Technologies Second-Quarter 2018 Results August 7, 2018 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements and are
More informationCantor Fitzgerald 2017 Global Healthcare Conference. September 26, 2017
Cantor Fitzgerald 2017 Global Healthcare Conference September 26, 2017 Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements, including statements
More information2017 WELLS FARGO HEALTHCARE CONFERENCE
2017 WELLS FARGO HEALTHCARE CONFERENCE September 7, 2017 TRANSFORMING HEALTHCARE TOGETHER UNIQUELY POSITIONED FOR THE FUTURE 2017 1 Craig McKasson Chief Financial Officer Premier Inc. TRANSFORMING HEALTHCARE
More informationReducing Costs, Improving Quality, Reinventing Healthcare
Reducing Costs, Improving Quality, Reinventing Healthcare J.P. Morgan Healthcare Conference 01.09.19 2018. All rights reserved. Premier Inc. Forward-looking statements and non-gaap financial measures Forward-looking
More informationWALGREEN CO FORM 8-K. (Current report filing) Filed 12/22/08 for the Period Ending 12/22/08
WALGREEN CO FORM 8-K (Current report filing) Filed 12/22/08 for the Period Ending 12/22/08 Address 200 WILMOT RD DEERFIELD, IL 60015 Telephone 8479402500 CIK 0000104207 Symbol WAG SIC Code 5912 - Drug
More informationInvestor Presentation
Investor Presentation J.P. Morgan 36 th Annual Healthcare Conference San Francisco, CA January 2018 Forward-Looking Statements This presentation contains forward-looking statements (as defined in the Securities
More informationShareholders Expected to Benefit from a Number of Outcomes
Shareholders Expected to Benefit from a Number of Outcomes Benefits for Shareholders F I N A N C I A L S U P P L E M E N T Enhanced competitive positioning Low- to mid-single digit accretion in the second
More informationCONSOLIDATED HIGHLIGHTS. Total Revenues $ 10,318 $ 9,960 $ 10,385 $ 20,703 Net Realized Investment Gains Consolidated Operating
Cigna Reports Strong Second Quarter 2017 Results, Raises Outlook BLOOMFIELD, Conn., 04 August, 2017 - Cigna Corporation (NYSE: CI) today reported second quarter 2017 results with strong performance across
More informationBERNSTEIN. 34 th Annual Strategic Decisions Conference. David Wichmann, CEO May 31, 2018
BERNSTEIN 34 th Annual Strategic Decisions Conference David Wichmann, CEO May 31, 2018 2018 UnitedHealth Group. All Rights Reserved. UnitedHealth Group is a registered trademark with the U.S. Patent and
More informationBaird 2018 Global Healthcare Conference. September 5, 2018
Baird 2018 Global Healthcare Conference September 5, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking statements,
More informationDaseke, Inc. Consolidating North America s Open Deck Transportation & Logistics Market Investor Presentation May 2017
Daseke, Inc. Consolidating North America s Open Deck Transportation & Logistics Market Investor Presentation May 2017 Important Disclaimers Forward-Looking Statements This presentation includes forward-looking
More informationSysco Earnings Results 2Q19
Sysco Earnings Results 2Q19 FORWARD LOOKING STATEMENTS Statements made in this presentation or in our earnings call for the second quarter of fiscal 2019 that look forward in time or that express management
More informationWellCare to Acquire Meridian
WellCare to Acquire Meridian May 9, 018 Cautionary Statements This presentation contains "forward-looking" statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation
More informationCowen and Company 38 th Annual Health Care Conference. March 13, 2018
Cowen and Company 38 th Annual Health Care Conference March 13, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute forward-looking
More informationMcKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS
McKESSON REPORTS FISCAL 2015 THIRD-QUARTER RESULTS Revenues of $47 billion for the third quarter, up 37%. Third-quarter GAAP earnings per diluted share from continuing operations of $2.01, up 187%. Third-quarter
More informationMcKESSON REPORTS FISCAL 2019 SECOND-QUARTER RESULTS
McKESSON REPORTS FISCAL 2019 SECOND-QUARTER RESULTS Revenues of $53.1 billion for the second quarter, up 2% year over year. Second-quarter GAAP earnings per diluted share from continuing operations of
More informationSysco 2Q16 Earnings Results. February 1, 2016
Sysco 2Q16 Earnings Results February 1, 2016 Forward-Looking Statements Statements made in this presentation or in our earnings call for the second quarter of fiscal 2016 that look forward in time or that
More informationR1 RCM Inc. (Exact Name of Registrant as Specified in Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationQ financial & business update. April 26, 2017
Q1 2017 financial & business update April 26, 2017 This presentation contains forward-looking statements about Castlight Health s expectations, plans, intentions, and strategies, including, but not limited
More informationPresenters. Thomas S. Hall. Timothy L. Fielding. Chairman & Chief Executive Officer. Chief Financial Officer
June 2, 2015 Disclaimer In addition to historical information, this presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the
More informationCIGNA REPORTS STRONG FIRST QUARTER 2018 RESULTS, RAISES OUTLOOK. Shareholders net income for the first quarter was $915 million, or $3.
NEWS RELEASE Contact: Will McDowell, Investor Relations (215) 761-4198 Matt Asensio, Media Relations (860) 226-2599 CIGNA REPORTS STRONG FIRST QUARTER 2018 RESULTS, RAISES OUTLOOK o o o o Total revenues
More informationReducing Costs, Improving Quality, Reinventing Healthcare
Reducing Costs, Improving Quality, Reinventing Healthcare Investor Information January 2019 2018. All rights reserved. Premier Inc. Forward-looking statements and non-gaap financial measures Forward-looking
More informationPress Release INVESTOR RELATIONS CONTACT: MEDIA CONTACT: Will McDowell 215-761-4198 william.mcdowell2@cigna.com Ellie Polack 860-902-4906 elinor.polack@cigna.com Cigna Delivers Strong 2018 Results as it
More informationMcKESSON REPORTS FISCAL 2015 SECOND-QUARTER RESULTS
McKESSON REPORTS FISCAL 2015 SECOND-QUARTER RESULTS Revenues of $44.8 billion for the second quarter, up 36%. Second-quarter GAAP earnings per diluted share from continuing operations of $2.05, up 13%.
More information